Clinical Trials Logo

Motor Tic Disorder clinical trials

View clinical trials related to Motor Tic Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT03625453 Completed - Tourette Syndrome Clinical Trials

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder

Start date: October 15, 2018
Phase: Phase 2
Study type: Interventional

Two-part study consisting of a double-blind, randomized, placebo-controlled, study at two target dose levels (Part 1) and an open-label, non-randomized study (Part 2) to determine the efficacy of ABX-1431 in treating adult patients with Tourette syndrome or Chronic Motor Tic Disorder as measured by the change from baseline in Total Tic Score of the Yale Global Tic Severity Scale (YGTSS-TTS) compared with placebo.

NCT ID: NCT00226824 Terminated - Tourette's Syndrome Clinical Trials

Safety Study of Galantamine in Tic Disorders

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.